Effect of melphalan dose adjustment in multiple myeloma patients undergoing autologous stem cell transplantation

被引：0
|
作者：
Gonzalez, A. P. [1 ]
Gonzalez, A. J. [1 ]
Palomo, P. [1 ]
Fernandez, R. [1 ]
Pardo, C. [1 ]
Alarcon, C. [1 ]
Fonseca, A. [1 ]
Fonseca, A. [1 ]
Gonzalez, S. [1 ]
Rayon, C. [1 ]
Vallejo, C. [1 ]
机构：
[1] Univ Cent Hosp Asturias, Oviedo, Spain
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S228 / S229
页数：2
相关论文
共 50 条
  • [31] Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation
    Martino, Massimo
    Gori, Mercedes
    Porto, Gaetana
    Pellicano, Maria
    Santoro, Ludovica
    Verduci, Chiara
    Canale, Filippo Antonio
    Loteta, Barbara
    Moscato, Tiziana
    Alati, Caterina
    Ieracitano, Maria Consuelo
    Cuzzocrea, Amelia
    Altomonte, Maria
    Florenzano, Maria Teresa
    Morabito, Antonella
    Irrera, Giuseppe
    Naso, Virginia
    Pugliese, Marta
    Console, Giuseppe
    Ferreri, Anna
    Imbalzano, Lucrezia
    Tripepi, Giovanni
    Pitino, Annalisa
    ANNALS OF HEMATOLOGY, 2023, 102 (07) : 1915 - 1925
  • [32] Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation
    Sneha Chitre
    Friedrich Stölzel
    Kirsty Cuthill
    Mathew Streetly
    Charlotte Graham
    Claudia Dill
    Azim Mohamedali
    Alexander Smith
    Johannes Schetelig
    Heidi Altmann
    Martin Bornhäuser
    Ghulam J. Mufti
    Leukemia, 2018, 32 : 2020 - 2024
  • [33] Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation
    Massimo Martino
    Mercedes Gori
    Gaetana Porto
    Maria Pellicano
    Ludovica Santoro
    Chiara Verduci
    Filippo Antonio Canale
    Barbara Loteta
    Tiziana Moscato
    Caterina Alati
    Maria Consuelo Ieracitano
    Amelia Cuzzocrea
    Maria Altomonte
    Maria Teresa Florenzano
    Antonella Morabito
    Giuseppe Irrera
    Virginia Naso
    Marta Pugliese
    Giuseppe Console
    Anna Ferreri
    Lucrezia Imbalzano
    Giovanni Tripepi
    Annalisa Pitino
    Annals of Hematology, 2023, 102 : 2297 - 2298
  • [34] Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation
    Massimo Martino
    Mercedes Gori
    Gaetana Porto
    Maria Pellicano
    Ludovica Santoro
    Chiara Verduci
    Filippo Antonio Canale
    Barbara Loteta
    Tiziana Moscato
    Caterina Alati
    Maria Consuelo Ieracitano
    Amelia Cuzzocrea
    Maria Altomonte
    Maria Teresa Florenzano
    Antonella Morabito
    Giuseppe Irrera
    Virginia Naso
    Marta Pugliese
    Giuseppe Console
    Anna Ferreri
    Lucrezia Imbalzano
    Giovanni Tripepi
    Annalisa Pitino
    Annals of Hematology, 2023, 102 : 1915 - 1925
  • [35] Feasibility of high dose busulfan and melphalan with autologous hematopoietic stem cell transplantation in multiple myeloma.
    Begum, U
    Fitzgerald, D
    Yong, LO
    Grand, M
    Thomas, U
    Chen, Y
    Patel, A
    Goodman, D
    Dillon, C
    Amorosi, E
    Cook, P
    BLOOD, 1997, 90 (10) : 4346 - 4346
  • [36] Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial
    Blanes, Margarita
    de la Rubia, Javier
    Lahuerta, Juan J.
    Gonzalez, Jose D.
    Ribas, Paz
    Solano, Carlos
    Alegre, Adrian
    Sanz, Miguel A.
    LEUKEMIA & LYMPHOMA, 2009, 50 (02) : 216 - 222
  • [37] Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell Transplantation
    Shultes, Kendall C.
    Arp, Christopher
    Stockerl-Goldstein, Keith
    Trinkaus, Kathryn
    DeFrates, Sean
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 687 - 693
  • [38] WEIGHING IN: ACTUAL VS IDEAL VS ADJUSTED BODY WEIGTH TO CALCULATE DOSE OF MELPHALAN IN PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION
    Kopp, Michelle
    Talamo, Giampaolo
    ONCOLOGY NURSING FORUM, 2015, 42 (02) : E155 - E155
  • [39] SUCCESSFUL STEM CELL MOBILIZATION AND ENGRAFTMENT IN HEAVILY PRETREATED MULTIPLE MYELOMA PATIENTS WITH PRIOR HIGH DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION
    Khaled, Y.
    Solh, M.
    Lamontagne, D.
    Batista, A.
    Sullivan, Y.
    Chan-Fong, S.
    Fondaw, M.
    Reddy, V
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S300 - S300
  • [40] Bortezomib and melphalan for autologous stem cell transplantation in multiple myeloma: preliminary results
    Kim, B. S.
    Kim, S. J.
    Sung, H. J.
    Choi, C. W.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S188 - S188
12345